Latest booster reduces adults' risk of moderate or severe COVID by more than half

Published on March 1, 2024

The most recent COVID-19 booster shot reduces adults' risk of moderate or severe COVID by more than half, according to a new nationwide data study from September 2023 through January 2024, a period of JN.1 variant dominance. The new study is one of the first to evaluate protection provided by the updated shot against COVID-19-associated emergency department and urgent care visits (markers for moderate disease) and against hospitalizations (a marker for severe disease), in individuals 18 and older, due to JN.1, the most recently predominant strain of COVID.

Continue reading on website
Other news

This Season's Flu Vaccines Reduced Flu Medical Visits and Hospitalizations Across All Ages

February 29, 2024
Interim flu vaccine effectiveness estimates show that so far during the 2023-2024 flu season, flu vaccines have worked, substantially reducing the risk of flu-related medical visits and hospitalizations across all age groups, with some estimates higher than have been previously observed, even during well-matched seasons.

New antibodies target 'dark side' of influenza virus protein

March 1, 2024
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The antibodies target a region of the NA protein that is common among many influenza viruses, including H3N2 subtype viruses, and could be a new target for countermeasures.